Runhua Tian

Runhua Tian

Auto-generated profile, based on publicly available information

Runhua Tian

University of Miami , Miami, FL

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Disease Markers
Verified
Journal Article
Open access
JSJunying Song
Junying Song
XCXian Chen
Xian Chen
QTQingwu Tian
Qingwu Tian
LLLimin Lun
Limin Lun
QWQing Wang
Qing Wang
RTRunhua Tian
Runhua Tian
Aim. There is increasing evidence that high expression levels of the gastric carcinoma highly expressed transcript 1 (GHET1), a long noncoding RNA (lncRNA), are associated with cancer prognosis and may be used as a valuable biomarker for cancer patients. The purpose of this meta-analysis was to analyze existing data to reveal potential clinical applications of GHET1 for cancer prognosis and tumor progression. All of these studies included in this meta-analysis were collected through a variety of retrieval strategies; and the enrolled articles were qualified via the meta-analysis of enrolled studies in epidemiology (MOOSE) and the preferred reporting items for systematic reviews and meta-analyses (PRISMA) checklists. Materials and Methods. The literature collection was performed by a comprehensive search through electronic databases for studies published on or before March 10, 2019. These included the Cochrane library, PubMed, Embase, Web of Science, Springer, Science Direct, and three Chinese databases: CNKI, Weipu, and Wanfang. Seven studies that met the specified criteria were analyzed in the present research. Results. The combined results indicate that an elevated GHET1 expression level is significantly associated with poor overall survival (OS) (HR=2.40, 95% CI: 1.87–3.08, p<0.001) and tumor progression (III/IV vs. I/II: HR=1.80, 95% CI: 1.48–2.18, p<0.001) in multiple cancers. The elevated GHET1 expression was also associated with lymph node metastasis (LNM) (HR=2.44, 95% CI: 1.86–3.20, p<0.001) in Chinese cancer patients. Conclusions. The present findings indicate that an increased GHET1 expression level is associated with poor OS, tumor progression, and LNM in patients with multiple tumors and may serve as a useful prognostic biomarker in Chinese cancer patients.

1 July 2020 in Microbial Pathogenesis
Verified
Journal Article
Closed access
TYTingfei Yan
Tingfei Yan
XTXiaoyan Tang
Xiaoyan Tang
LSLei Sun
Lei Sun
RTRunhua Tian
Runhua Tian
ZLZhiming Li
Zhiming Li
GLGuangzhen Liu
Guangzhen Liu

1 January 2019 in Clinical Laboratory
Verified
Journal Article
Closed access
LTLiyuan Tian
Liyuan Tian
XCXian Chen
Xian Chen
LLLimin Lun
Limin Lun
QTQingwu Tian
Qingwu Tian
QWQing Wang
Qing Wang
RTRunhua Tian
Runhua Tian
Background: Mounting evidence from recent studies has revealed the association of lncRNA PANDAR expression levels with outcomes in several types of cancer. However, inconsistent results have also been reported, which rationalized a meta-analysis of available data to analyze the prognostic value of lncRNA PANDAR. Methods: From inception to May 26, 2018, electronic literature databases including PubMed (medline), the Cochrane Library, ScienceDirect, Springer, ISI Web of Knowledge, Wiley Online library, BioMed Central, and Embase were searched for literature collections. The hazard ratios (HR) with 95% confidence interval (95% CI) were utilized to calculate pooled effect size. Results: A total of 1,132 cancer patients were enrolled in the present meta-analysis to assess the prognostic value of PANDAR in various carcinomas. Promoted PANDAR expression was demonstrated to significantly predict unfavorable OS (HR = 1.77, 95% CI: 1.12 - 2.80, p = 0.014) by the random effects model. According to the stratified analyses and meta-regression results, the heterogeneity of present analysis may be attributed to the differences of cancer resources. Furthermore, over-expression of PANDAR was revealed to be effectively predictive of cancer progression (HR = 1.70, 95% CI: 1.41 - 2.05, p < 0.00001) and LNM (HR = 1.71, 95% CI: 1.39 - 2.10, p < 0.00001). Conclusions: The present findings indicate that increased PANDAR is associated with poor OS in patients with general carcinomas and may serve as a useful clinical prognostic biomarker.


1 February 2010 in Journal of Surgical Research
Verified
Journal Article
Closed access
PDF file
ZLZ. Liu
Z. Liu
RTR. Tian
R. Tian
HSH. Shao
H. Shao
YZY. Zhuge
Y. Zhuge
YLY. Li
Y. Li
OVOmaida Caridad Velazquez
Omaida Caridad Velazquez